Eco Animal Health said it had entered into a second exclusive research partnership with the UK's Pirbright Institute, to develop another novel vaccine for use in chickens. Technologies developed at Pirbright would be used to generate protective components against diseases including infectious bursal disease virus, Newcastle disease virus and infectious laryngotracheitis. 'The use of the Marek's disease vector in this technology is a significant advancement over other recombinant vaccines and will help widen the potential use of this vaccine in broilers and in breeding stock,' chief executive Marc Loome said. At 2:51pm: (LON:EAH) Eco Animal Health Group PLC share price was 0p at 367p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.